Prisma Health-Upstate Cancer Institute — Greenville, South Carolina

Prisma Health-Upstate Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Prisma Health-Upstate Cancer Institute has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumors, Metastatic Cancer, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

Sponsors: Astellas Pharma Global Development, Inc., SWOG Cancer Research Network, Poseida Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greenville

Browse all research sites in South Carolina · View every site in Greenville

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health-Upstate Cancer Institute?

Prisma Health-Upstate Cancer Institute has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health-Upstate Cancer Institute conducted?

Prisma Health-Upstate Cancer Institute has 5 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Metastatic Cancer, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

Is Prisma Health-Upstate Cancer Institute accredited by Crixeo Clinical Trials?

Prisma Health-Upstate Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prisma Health-Upstate Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.